NorthWest Biotherapeutics Inc (NWBO)

[Slave1]

MHRA approval generally follows the completion of final labeling and licensing steps. NICE already confirmed NWBO is “not yet in a position to submit evidence,” which only happens after MHRA approval. That means we’re in the very final regulatory window now.

A decision could land any day.